PTC is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. While PTC's disco...
PTC is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. While PTC's discovery programs are directed at targets in multiple therapeutic areas, PTC is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. For more information on the company, please visit our website www.ptcbio.com.
Public Symbol
PTCT
Founded Year
1998
Organization Website
ptcbio.com
Organization Languages
English
Organization Revenue
36800
Alexa Ranking
309870
Current Technologies
csc corporate domains
mimecast
office 365
rackspace
mobile friendly
asp net
google analytics
kenexa
apache
omniture adobe
Job Functions
Human Resources
Finance
Education
Marketing
Operations
Business Development
Consulting
Media And Commmunication
Accounting
Legal
Information Technology
Sales
Engineering
Support
Product Management
Data Science
oncology
antiinfectives
orphan & ultraorphan disorders
healthcare
biotechnology
therapeutics
health care
hospital & health care
health
wellness & fitness
Neil Almstead's Work History and Education
PTC Therapeutics, Inc.
Executive Vice President Research, Pharmaceutical Operations and Technology